Hui Wang
Direttore/Membro del Consiglio presso Hebei Zhongnuo Pharmaceutical Technology Co., Ltd.
Patrimonio netto: 83 565 $ in data 30/04/2024
Profilo
Hui Wang is currently working as an Executive Director & Manager at Hebei Zhongnuo Pharmaceutical Technology Co., Ltd.
Prior to this, Mr. Wang worked as a Director at CSPC Innovation Pharmaceutical Co., Ltd.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 30/09/2023 | 17 658 ( 0.01% ) | 83 565 $ | 30/04/2024 |
Posizioni attive di Hui Wang
| Società | Posizione | Inizio |
|---|---|---|
Hebei Zhongnuo Pharmaceutical Technology Co., Ltd.
 Hebei Zhongnuo Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of CSPC Pharmaceutical Group Ltd., Hebei Zhongnuo Pharmaceutical Technology Co., Ltd. manufactures and distributes pharmaceutical products. The company is based in Shijiazhuang, China. The Chinese company was founded in 2020. Hebei Zhongnuo Pharmaceutical Technology Co. was acquired by CSPC NBP Pharmaceutical Co., Ltd. from CSPC Innovation Pharmaceutical Co., Ltd. on May 08, 2021 for $18.71 million. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Hui Wang
| Società | Posizione | Fine |
|---|---|---|
| CSPC INNOVATION PHARMACEUTICAL CO., LTD. | Direttore/Membro del Consiglio | 12/04/2023 |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
| CSPC Innovation Pharmaceutical Co., Ltd. | |
Hebei Zhongnuo Pharmaceutical Technology Co., Ltd.
Hebei Zhongnuo Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of CSPC Pharmaceutical Group Ltd., Hebei Zhongnuo Pharmaceutical Technology Co., Ltd. manufactures and distributes pharmaceutical products. The company is based in Shijiazhuang, China. The Chinese company was founded in 2020. Hebei Zhongnuo Pharmaceutical Technology Co. was acquired by CSPC NBP Pharmaceutical Co., Ltd. from CSPC Innovation Pharmaceutical Co., Ltd. on May 08, 2021 for $18.71 million. | Health Technology |
- Borsa valori
- Insiders
- Hui Wang
